Q4 2025 Vext Science Inc Earnings Call Transcript
Key Points
- Vext Science Inc (VEXTF) reported a 35% year-over-year increase in fourth-quarter revenue, reaching $13.7 million.
- The company achieved a 43% year-over-year revenue growth for the full year 2025, totaling $51.4 million.
- Operating cash flow for the full year increased by 256% year-over-year to $11.7 million, indicating strong cash generation.
- Ohio retail operations accounted for over half of consolidated revenue, with sales increasing over 120% year-over-year.
- The company is expanding its retail footprint in Ohio, with plans to open additional stores, including a drive-thru format in Fairfield, which is expected to enhance revenue and cash flow.
- Vext Science Inc (VEXTF) reported a negative $3 million EBITDA in Q4 due to a $5 million non-cash impairment on a Columbus, Ohio dispensary.
- The Arizona market remains challenging with a 3% decline in total cannabis sales and a 7-8% drop in average item prices year-over-year.
- The company is exiting cultivation in Arizona due to continued pricing pressure and excess supply, which may impact future revenue streams.
- Operating expenses increased by 31% year-over-year, primarily due to the $5 million impairment related to the Columbus-Ohio dispensary.
- The company's working capital at the end of 2025 was negative, driven by an $8.1 million uncertain tax position.
Thank you for standing by. This is the conference operator. Welcome to the VEXT Science First Quarter and Full Year 2025 Financial Results Conference Call. (Operator Instructions) I would now like to turn the conference over to Priyam Chakraborty. Please go ahead.
Thanks, operator. Good morning, everyone, and thank you for joining us today. VEXT's fourth quarter and fiscal year 2025 financial results were released earlier this morning. The press release, financial statements, and MD&A are available on CDAR+ as well as on the VEXT website at vextscience.com. We would like to remind listeners that portions of today's discussion include forward-looking statements and that forward-looking statements are included in today's filings.
There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances, or results contained therein will materialize. Risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
